Schedule 13G ownership disclosure
RAPT THERAPEUTICS INC
Common Stock, $0.0001 par value per share · CUSIP: 75382E109
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RTW Investments, LP
Shares: 11,764,000 · Class: 8.9%
- Roderick Wong, M.D.
Shares: 11,764,000 · Class: 8.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-072012
- Form type
- SCHEDULE 13G
- Filer
- RAPT Therapeutics, Inc.
- CIK
- CIK 1673772
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership